CD19 and leukemia: Finally, the CD19 CAR construct was flanked with piggyBac transposase elements and introduced into the DNA of the T cells through a cut‐and‐paste mechanism.[35] Interestingly, the therapeutic efficacy of their nanoparticle system was similar to CAR‐T cells generated ex vivo in an animal model with CD19+ leukemia.